Myometrial maturation and labour

Annals of Medicine

Volumn 33, Issue 9, 2001, Pages 571-578

  Carbillon, Lionel ^a   Seince, Nathalie ^a   Uzan, Michele ^a  

^a HÔPITAL JEAN VERDIER   (France)

Author keywords

Endothelin; Gap junctions; Labour; Myometrium; Nitric oxide; Oxytocin; Parturition; Prostaglandins; Receptors

Indexed keywords

CALCIUM ION; CONNEXIN 43; ENDOTHELIN 1; EPIDERMAL GROWTH FACTOR; ICOSANOID; INTERLEUKIN 1; NITRIC OXIDE; OXYTOCIN; OXYTOCIN RECEPTOR; PROSTAGLANDIN; PROSTAGLANDIN F2 ALPHA; PROSTAGLANDIN RECEPTOR; TUMOR NECROSIS FACTOR ALPHA; UTEROTONIC AGENT; UTERUS SPASMOLYTIC AGENT;

AMNION; CALCIUM CELL LEVEL; CELL MATURATION; CHORION; CYTOKINE PRODUCTION; DECIDUA; DOWN REGULATION; DRUG TARGETING; HORMONE ACTION; HUMAN; LABOR; LABOR INDUCTION; MYOMETRIUM; NONHUMAN; PREGNANCY; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; PROTEIN EXPRESSION; RECEPTOR INTRINSIC ACTIVITY; REVIEW; TOCOLYSIS; UTERUS CONTRACTILITY; UTERUS RELAXATION;

ENDOTHELIN-1; ENDOTHELINS; FEMALE; GAP JUNCTIONS; GTP-BINDING PROTEINS; HUMANS; LABOR, OBSTETRIC; MYOMETRIUM; PREGNANCY; RECEPTORS, OXYTOCIN; RECEPTORS, PROSTAGLANDIN; RECEPTORS, PROSTAGLANDIN E; SIGNAL TRANSDUCTION;

EID: 0035683059     PISSN: 07853890     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (90)

1. Plasma, membrane receptors regulating myometrial contractility and their hormonal modulation
2. Fetal-placental and decidual-placental units: Role of endocrine and paracrine regulations in parturition
3. Progesterone increases cAMP release and accumulation in isolated term human myometrium
4. Effects of cGMP on Ca2+ myosin light chain phosphorylation, and contraction in human myometrium
5. Involvement of a nitric oxide-cGMP pathway in control of human uterine contractility during pregnancy
6. Nitric oxide relaxes human myometrium by a cGMP-independent mechanism
7. Identification and expression of G-proteins in human myometrium: Up-regulation of G alpha s in pregnancy
8. Down-regulation of G alpha s in human myometrium in term and preterm: A mechanism for parturition
9. Parturition: Activation of stimulatory pathways or loss of uterine quiescence?
10. Preterm labour: A pharmacological challenge
11. The differential expression of myometrial connexin-43, cyclooxygenase-1 and -2, and Gs alpha proteins in the upper and lower segments of the human uterus during pregnancy and labor
12. Correlation between the stimulatory effect of oxytocin on the formation of inositol phosphates and the oxytocin receptor level in the pregnant rabbit myometrium
13. Correlation between oxytocin receptor concentration and responsiveness to oxytocin in pregnant rat myometrium: Effects of ovarian steroids
14. Oxytocin receptors in the human uterus during pregnancy and parturition
15. Oxytocin receptors and human parturition: Dual role for oxytocin in the initiation of labor
16. Structure and expression of a human oxytocin receptor
17. Expression of oxytocin receptor in human pregnant myometrium
18. Effects of sodium and calcium channel blockade on cytosolic calcium oscillations and phasic contractions of myometrial tissue
19. Oxytocin-stimulated phosphoinositide hydrolysis in human myometrial cells: Involvement of pertussis toxin-sensitive and -insensitive G-proteins
20. Molecular mechanisms regulating the effects of oxytocin on myometrial intracellular calcium
21. Oxytocin-induced Ca2+ responses in human myometrial cells
22. Oxytocin-stimulated capacitative calcium entry in human myometrial cells
23. Multiple G proteins and phospholipase C isoforms in human myometrial cells: Implication for oxytocin action
24. Oxytocin stimulates myometrial guanosine triphosphatase and phospholipase-C activities via coupling to G alpha q/11
25. Mechanisms regulating oxytocin receptor coupling to phospholipase C in rat and human myometrium
26. Oxytocin receptor couples to the 80-kDa h alpha family protein in human myometrium
27. Phospholipase C-delta1 and oxytocin receptor signalling: Evidence of its role as an effector
28. Biomolecular processes in the initiation of parturition: Decidual activation
29. Endocrinology of human parturition: A review
30. Gap junction formation in myometrium: Control by oestrogens, progesterone and prostaglandins
31. Increased expression of connexin-43 in the rat myometrium during labor is associated with an increase in the plasma oestrogen: Progesterone ratio
32. Myometrial transcriptional regulation of the gap junction gene, connexin-43
33. Hormonal control of gap junction in the myometrium
34. Steroid hormone regulation of rat myometrial gap junction formation: Effects on cx43 levels and trafficking
35. Novel regulation of pregnant human myometrial smooth muscle cell gap junctions by human chorionic gonadotropin
36. An immunohistochemical and immunocytologic study of the increase in myometrial gap junctions (and connexin 43) in rats and humans during pregnancy
37. Expression of the gap junction protein connexin-43 is increased in the human myometrium toward term and with the onset of labor
38. Effect of progesterone and oestradiol on expression of connexin43 in cultured human myometrial cells
39. Progesterone, oestradiol and oxytocin and their in vitro effect on maintaining the number of gap junction plaques in human myometrium at term
40. Role of gap junctions and nitric oxide in control of myometrial contractility
41. Mechanisms of the onset of labour: The New Zealand perspective
42. Prostaglandins and parturition
43. Fluprostenol activates phospholipase C and Ca2+ mobilization in human myometrial cells
44. Intracellular calcium stores and agonist-induced contractions in isolated human myometrium
45. Prostaglandin F2alpha-induced Ca++ oscillations in human myometrial cells and the role of RU 486
46. Regulation of intracellular free calcium in human myometrial cells by prostaglandin F2 alpha: Comparison with oxytocin
47. In vitro characterization of prostanoid EP-receptors in the nonpregnant human myometrium
48. In vitro characterization of prostanoid receptors on human myometrium at term pregnancy
49. Expression of cyclooxygenase-2 and prostanoid receptors by human myometrium
50. Classification of prostanoid receptors: Properties, distribution, and structure of the receptors and their subtypes
51. Prostaglandin E2 activates phospholipase C and elevates intracellular calcium in cultured myometrial cells: Involvement of EP1 and EP3 receptor subtypes
52. Molecular mechanisms of diverse actions of prostanoid receptors
53. Alternative splicing of C-terminal tail of prostaglandin E receptor subtype EP3 determines G-protein specificity
54. The prostaglandin E2 and F2 alpha receptor genes are expressed in human myometrium and are down-regulated during pregnancy
55. Prostaglandin receptors in lower segment myometrium during gestation and labor
56. Changes in expression of contractile FP and relaxatory EP2 receptors in pregnant rat myometrium during late gestation, at labor, and postpartum
57. Pregnancy and exogenous steroid treatments modulate the expression of relaxant EP (2) and contractile FP receptors in the rat uterus
58. Contragestion by antiprogestin: A new approach to human fertility control
59. Mifepristone (RU 486) and therapeutic late pregnancy termination: A double-blind study of two different doses
60. Amniotic fluid prostanoid concentrations increase early during the course of spontaneous labor at term
61. Changes in prostaglandin transfer across human fetal membranes obtained after spontaneous labour
62. The role of prostaglandins in human parturition
63. Prostaglandins and parturition
64. Effects of gestational age on prostaglandin production and its regulation in human myometrial cells
65. Oxytocin activates mitogen-activated protein kinase and up-regulates cyclooxygenase-2 and prostaglandin production in human myometrial cells
66. Immunolocalization of eicosanoid enzymes and growth factors in human myometrium and fetoplacental tissues in failed labor inductions
67. Endothelins: Polyfunctional cytokines
68. Endothelin expression in the uterus
69. Uterine contractile responses to ET-1 and ET receptors are elevated during labor
70. Effects of endothelins on mechanical activity and inositol phosphate production in pregnant rat myometrium
71. Contractile effects of ET-1 and ET-3 on myometrium and small intramyometrial arteries of pregnant women at term
72. Endothelin ETA receptors mediate human uterine smooth muscle contraction
73. Pregnancy increases ET-1-induced contraction and exchanges receptors sub-types in uterine smooth muscle in humans
74. Endothelin receptor is coupled to phospholipase C via pertussis toxin-insensitive guanine nucleotide binding regulatory protein in vascular smooth muscle
75. Endothelin receptors: Binding and phosphoinositide breakdown in human endometrium
76. Expression of endothelin receptors in human myometrium during pregnancy and in uterine leiomyomas
77. Endothelin-1 potentates the in vitro contractile response of pregnant human myometrium to oxytocin
78. Urinary trypsin inhibitor prevents uterine muscle contraction by inhibition of Ca++ influx
79. Effects of urinary trypsin inhibitor on myometrial contraction in term and preterm deliveries
80. Urinary trypsin inhibitor suppresses vascular smooth muscle contraction by inhibition of Ca++ influx
81. Urinary trypsin inhibitor levels in amniotic fluid of normal human pregnancy: Decreased levels observed at parturition
82. Rat myometrial smooth muscle cells express endothelial nitric oxide synthase
83. NO synthase activity in pregnant rabbit uterus decreases on the last day of pregnancy
84. Endogenous nitric oxide suppresses rat myometrial connexin 43 gap junction protein expression during pregnancy
85. Maternal or umbilical venous levels of nitrite/nitrate during pregnancy and at delivery
86. A decline in myometrial nitric oxide synthase expression is associated with labor and delivery
87. Involvement of calcitonin gene-related peptide in the modulation of human myometrial contractility during pregnancy
88. Parathyroid hormone-related protein and human myometrial cells: Action and regulation
89. The human myometrial CRH receptor: G proteins and second messengers
90. The biological activity of the corticotropin-releasing hormone receptor-adenylate cyclase complex in human myometrium is reduced at the end of pregnancy